Pharmaceuticals

#Clinical research #Innovation Centre 7 #Keele University #Keele University Science & Innovation Park #Panthera #Pharmaceuticals

Panthera clinical research network expands to Keele University

Site management organisation Panthera has opened its latest clinical trial clinic at Keele University, strengthening its growing clinical research network across the UK and Europe. Panthera recruits patients and runs clinical trials on behalf of pharmaceutical companies. The opening of the Keele site brings Panthera’s network to 11 sites, including… Read More

#News

#Biotechnology #Cardiometabolic diseases #Drug development #Drug discovery #ICON #Pharmaceuticals #Survey

More efficient next-gen obesity clinical trials needed, says survey

ICON has released the findings of a survey of 155 biotech and pharma professionals from across the US and Europe, focusing on multi-indication cardiometabolic R&D for therapies targeting obesity and its comorbidities. Multi-indication studies are clinical trials that test how a treatment works for more than one condition or disease. Read More

#News

Magnifying glass
#Big pharma #Novo Nordisk #Pharmaceuticals #University of Bath

Critics say pharma giant has “deep cultural issues”

The UK’s Channel 4’s Dispatches: Skinny Jab Scandal investigational documentary has highlighted significant concerns about pharmaceutical giant Novo Nordisk’s promotional practices. Here, DDW outlines the case and provides comment from a Novo Nordisk spokesperson. The documentary featured expert insights from Dr Piotr Ozieranski and Dr Emily Rickard of the University… Read More

#Business & Investment #News

#AI / data analytics / healthtech / informatics #Business #Digital solutions #Digital workflow #Drug development #Drug discovery #EMA #FDA #Marketing #Pharmaceuticals #Regulatory

New podcast: How to streamline regulatory approval

This is the latest episode of the free DDW narrated podcast, titled “How to streamline regulatory approval”, which covers two articles written for Volume 24 – Issue 1, Winter 2022/2023 of DDW. They are called: Quicker time to regulatory submission through improved data management and The… Read More

#News #Regulatory

#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Automated workflows #Automation #Automation / robotics #Biopharma #Biopharmaceuticals #Data science #Drug development #Drug discovery #Lab automation #Lab technology #Personalised medicine #Pharmaceuticals

New podcast: How technology is impacting drug discovery

This is the latest episode of the free DDW narrated podcast, titled “How technology is impacting drug discovery”, which covers two articles written for Volume 24 – Issue 1, Winter 2022/2023 of DDW. They are called: AI is critical to solving new complexities in drug discovery and… Read More

#News

International Space Station (ISS)
#Drug development #Drug discovery #Eli Lilly #Lab space #Pharmaceuticals #Redwire

First spaceflight mission for drug development lab

Redwire will launch its in-space pharmaceutical manufacturing platform, PIL-BOX, onboard SpaceX’s 29th cargo resupply services mission (SpaceX-29) for NASA to the International Space Station (ISS). The platform is designed to offer pharmaceutical companies and researchers novel and flexible services to grow small-batch crystals of protein-based pharmaceuticals… Read More

#Editor's Choice #News

The European Medicines Agency building
#EFPIA #Europe #Orphan drugs #Pharmaceuticals #Rare disease #Regulatory

Proposed changes to EU regulation risks progress on orphan drugs

Plans to overhaul the EU regulation on rare disease therapies risk undermining two decades of progress, a new report claims. The assessment, commissioned by the European Federation of Pharmaceutical Industries and Associations (EFPIA), was conducted by Dolon, a strategic consultancy specialising in rare diseases. Read More

#News #Regulatory

AIDS
#AIDs #American Association of Pharmaceutical Scientists #Cambridge Crystallographic Data Centre #Collaboration #Pharmaceuticals #Research

CCDC AIDS research wins AAPS pharma award 

A Cambridge Crystallographic Data Centre (CCDC) research paper has won an Outstanding Manuscript Award from the American Association of Pharmaceutical Scientists (AAPS).  The research paper, Solid-State and Surface Structures of the Conformational Polymorphic Forms of Ritonavir in Relation to their Physicochemical Properties, published in the… Read More

#News

Networked world map
#CNS #Neuraxpharm #Pharmaceuticals

Neuraxpharm expands outside Europe into Brazil and Mexico 

Neuraxpharm Group, a European specialty pharmaceutical company focused on the treatment of central nervous system (CNS) disorders, has established affiliates in Brazil and Mexico, the two largest pharmaceutical markets in Latin America1, as first steps in its expansion outside of Europe.  As part of the… Read More

#News #Regulatory

Heart
#Cardioprotection #Clinical trials #Heart attack #Pharmaceuticals

Successful Phase I results for cardioprotective drug 

Serca Pharmaceuticals, a cardioprotection company that is developing 13-M, a novel first in class treatment for minimising tissue damage that occurs with blood reperfusion post myocardial infarction (MI) and stenting, has presented data on a novel approach to modulate the beta-adrenergic receptor-cAMP protein kinase A (PKA) signalling pathway that… Read More

#News

Cancer cell
#Biotech #Cancer #iOnctura #Oncology #Pharmaceuticals

iOnctura expands pipeline and receives development grant 

iOnctura, a clinical-stage biotech developing selective cancer therapies against targets that play critical roles in multiple tumour survival pathways, has exercised an exclusive option with Clavius Pharmaceuticals, adding the novel oral TGF-β pathway inhibitor, IOA-359, to its pipeline.   IOnctura also announced it has, in collaboration with the… Read More

#News

Hyderabad
#Biotech hubs #Drug discovery hotspots #India #Life sciences #Pharmaceuticals

Drug discovery hotspots: India’s Genome Valley

Could India become an important centre of drug discovery innovation? Diana Spencer explores the evolution of the Hyderabad life sciences hub. India is traditionally known as ‘the pharmacy of the world’ due to its huge pharmaceuticals manufacturing capacity and high quantity of exports, particularly generic medicines… Read More

#Exclusive Content #Market Reports

In vitro diagnostics
#Clinical trials #EFPIA #EU #European Federation of Pharmaceutical Industries and Associations #In vitro #Pharmaceuticals #Regulatory

New EU in vitro regulations delaying clinical trials

New EU legislation designed to improve public health is delaying clinical trials and blocking access to new treatments for cancer and rare diseases, says the European Federation of Pharmaceutical Industries and Associations (EFPIA). The number of clinical trials delayed is expected to run into the hundreds,… Read More

#News #Regulatory

#Drug development #Drug discovery #Imaging #Magnetic Resonance Imaging (MRI) #Pharmaceuticals #Technology

eBook: Imaging and drug discovery

A new eBook is now available for download. This latest eBook sponsored by Bethyl Laboratories/Fortis Life Science features expert opinions on how imaging technologies are informing drug discovery and bringing more insight into treating diseases. Download this exclusive eBook to learn more about: The importance of imaging… Read More

#News